Failure to administer recommended chemotherapy: acceptable variation or cancer care quality blind spot?
Ryan J EllisCary Jo R SchlickJoe FeinglassMary F MulcahyAl B BensonSheetal M KircherTony D YangDavid D OdellKarl BilimoriaRyan P MerkowPublished in: BMJ quality & safety (2019)
Though overall rates are low, failure to receive recommended chemotherapy is associated with sociodemographic factors. Hospital variation in failure to administer recommended chemotherapy is masked by current quality measure definitions and may define a significant and unmeasured difference in hospital quality.